Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (242) 242
Publication (49) 49
Book Review (11) 11
Patent (5) 5
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (177) 177
humans (175) 175
female (165) 165
adult (106) 106
uterine cervical neoplasms - virology (87) 87
cervical cancer (86) 86
cancer (70) 70
adolescent (68) 68
papillomavirus infections - virology (68) 68
human papillomavirus (65) 65
risk factors (63) 63
women (63) 63
oncology (60) 60
papillomaviridae - genetics (60) 60
papillomavirus infections (57) 57
cervical intraepithelial neoplasia - virology (56) 56
papillomaviridae - isolation & purification (52) 52
abridged index medicus (49) 49
middle aged (47) 47
papillomavirus infections - prevention & control (46) 46
cervical intraepithelial neoplasia (42) 42
infection (42) 42
vaccines (42) 42
young adult (42) 42
uterine cervical neoplasms - prevention & control (38) 38
papillomavirus infections - epidemiology (37) 37
young-women (37) 37
uterine cervical neoplasms - epidemiology (36) 36
article (34) 34
polymerase chain reaction (34) 34
intraepithelial neoplasia (33) 33
prevention (33) 33
public, environmental & occupational health (32) 32
risk (32) 32
uterine cervical neoplasms - pathology (32) 32
infectious diseases (30) 30
papillomaviridae - classification (30) 30
research (30) 30
uterine cervical neoplasms - diagnosis (29) 29
lesions (28) 28
papillomavirus infections - complications (28) 28
viruses (28) 28
cervical intraepithelial neoplasia - pathology (27) 27
cervical intraepithelial neoplasia - epidemiology (26) 26
cervical-cancer (26) 26
dna, viral - analysis (26) 26
genotype (26) 26
undetermined significance (26) 26
vaccination (26) 26
double-blind method (25) 25
prevalence (25) 25
randomized-trial (25) 25
colposcopy (24) 24
diagnosis (24) 24
health aspects (24) 24
hpv (24) 24
microbiology (24) 24
vaginal smears (24) 24
atypical squamous-cells (23) 23
female genital diseases and pregnancy complications (23) 23
follow-up studies (23) 23
immunology (23) 23
infections (23) 23
united-states (23) 23
aged (21) 21
cervical intraepithelial neoplasia - diagnosis (21) 21
epidemiology (21) 21
papillomavirus vaccines - administration & dosage (21) 21
papillomaviruses (21) 21
virology (21) 21
immunization (20) 20
papillomaviridae - immunology (20) 20
papillomavirus infections - diagnosis (20) 20
papillomavirus infections - pathology (19) 19
particle vaccine (19) 19
virus diseases (19) 19
analysis (18) 18
cervical intraepithelial neoplasia - prevention & control (18) 18
dna (18) 18
dna, viral - genetics (18) 18
obstetrics & gynecology (18) 18
medical screening (17) 17
neoplasia (17) 17
papillomavirus vaccines (17) 17
womens health (17) 17
human papillomavirus 16 - immunology (16) 16
management (16) 16
new mexico - epidemiology (16) 16
cervix uteri - virology (15) 15
human papillomavirus 16 - genetics (15) 15
human papillomavirus 18 - immunology (15) 15
papillomavirus vaccines - immunology (15) 15
base sequence (14) 14
case-control studies (14) 14
early detection of cancer (14) 14
papillomavirus vaccines - therapeutic use (14) 14
age factors (13) 13
cytology interpretations (13) 13
dna, viral - isolation & purification (13) 13
follow-up (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The safety of Cervarix? – Authors' reply
by Wheeler, Cosette M and Struyf, Frank and HPV-015 study group
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 20 - 21
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S1473-3099(16)30540-0 Byline: Cosette M Wheeler (a), Frank Struyf (b)... 
Infectious Disease | Studies | Clinical trials | Human papillomavirus | Vaccines | Pharmaceutical industry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial
by Mao, Constance and Koutsky, Laura A and Ault, Kevin A and Wheeler, Cosette M and Brown, Darron R and Wiley, Dorothy J and Alvarez, Frances B and Bautista, Oliver M and Jansen, Kathrin U and Barr, Eliav and Proof Principle Study
Obstetrics and Gynecology, ISSN 0029-7844, 2006, Volume 107, Issue 1, pp. 18 - 27
OBJECTIVE: Human papillomavirus (HPV) virus-like particle (VLP) vaccines have demonstrated effectiveness in preventing persistent HPV infections. Whether... 
RESPONSES | METAANALYSIS | VIRUS-LIKE PARTICLES | ANTIBODY | INFECTION | TYPE-16 | YOUNG-WOMEN | CANCER | LESIONS | OBSTETRICS & GYNECOLOGY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Uterine Cervical Neoplasms - prevention & control | Reference Values | Cervical Intraepithelial Neoplasia - virology | Viral Vaccines - administration & dosage | Papillomaviridae - immunology | Vaccination - methods | Time Factors | Antibodies, Viral - analysis | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Vaccines | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort
by Kamineni, Aruna and Tiro, Jasmin A and Beaber, Elisabeth F and Silverberg, Michael J and Wheeler, Cosette M and Chao, Chun R and Chubak, Jessica and Skinner, Celette Sugg and Corley, Douglas A and Kim, Jane J and Balasubramanian, Bijal A and Paul Doria‐Rose, V and PROSPR Consortium and PROSPR consortium
International Journal of Cancer, ISSN 0020-7136, 03/2019, Volume 144, Issue 6, pp. 1460 - 1473
Little is known about the effect of evolving risk‐based cervical cancer screening and management guidelines on United States (US) clinical practice and patient... 
Pap test | cancer screening | cervical cancer | human papillomavirus | UNITED-STATES | ONCOLOGY | GUIDELINES | PERSONALIZED REGIMENS | CONCEPTUAL-MODEL | United States - epidemiology | Early Detection of Cancer - methods | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Mass Screening - statistics & numerical data | Cervix Uteri - diagnostic imaging | Uterine Cervical Neoplasms - pathology | Mass Screening - methods | Socioeconomic Factors | Young Adult | Papanicolaou Test - statistics & numerical data | Aged, 80 and over | Adult | Cervix Uteri - pathology | Female | Papillomavirus Infections - virology | Colposcopy - statistics & numerical data | Papillomavirus Vaccines - administration & dosage | Early Detection of Cancer - statistics & numerical data | Uterine Cervical Neoplasms - diagnosis | Risk Factors | Uterine Cervical Neoplasms - prevention & control | Biopsy - statistics & numerical data | Papillomavirus Infections - prevention & control | Aged | Longitudinal Studies | Cohort Studies | Health care | Immunization | Colposcopy | Vaccination | Health risks | Risk analysis | Medical screening | Minority & ethnic groups | Risk factors | Consortia | Screening | Human papillomavirus | Biopsy | Diagnostic systems | Health risk assessment | Cervical cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S
by Castle, Philip E and Wheeler, Cosette M and Campos, Nicole G and Sy, Stephen and Burger, Emily A and Kim, Jane J and New Mexico HPV Pap Registry Steer and New Mexico HPV Pap Registry Steering Committee
Preventive Medicine, ISSN 0091-7435, 06/2018, Volume 111, pp. 177 - 179
There is limited information on the cost-inefficiencies of non-adherence to recommended cervical cancer screening or the potential value for improving... 
MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | METAANALYSIS | Early Detection of Cancer - economics | Quality-Adjusted Life Years | Guidelines as Topic | Uterine Cervical Neoplasms - diagnosis | Mass Screening - economics | United States | Humans | Papillomavirus Infections - diagnosis | Papillomavirus Infections - economics | New Mexico | Cost-Benefit Analysis | Uterine Cervical Neoplasms - economics | Adult | Female | Prevention | Women | Medical colleges | Analysis | Diagnosis | Epidemiology | Health aspects | Cervical cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort
: Cervical cancer screening research
by Kamineni, Aruna and Tiro, Jasmin A and Beaber, Elisabeth F and Silverberg, Michael J and Wheeler, Cosette M and Chao, Chun R and Chubak, Jessica and Skinner, Celette Sugg and Corley, Douglas A and Kim, Jane J and Balasubramanian, Bijal A and Paul Doria-Rose, V and on behalf of the PROSPR consortium
International Journal of Cancer, ISSN 0020-7136, 03/2019, Volume 144, Issue 6, pp. 1460 - 1473
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Fewer than three doses of HPV vaccine – Authors' reply
by Kreimer, Aimée R and Struyf, Frank and Hildesheim, Allan and David, Marie-Pierre and Wheeler, Cosette M and all authors of the manuscript
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. e424 - e425
Hematology, Oncology and Palliative Medicine | Adjuvants, Immunologic - administration & dosage | Papillomavirus Infections - prevention & control | Humans | Cervical Intraepithelial Neoplasia - prevention & control | Female | Papillomavirus Vaccines - administration & dosage | Cervical Intraepithelial Neoplasia - virology | Papillomavirus infections | Vaccines | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548]
by Gage, Julia C and Joste, Nancy and Ronnett, Brigitte M and Stoler, Mark and Hunt, William C and Schiffman, Mark and Wheeler, Cosette M
Human pathology, ISSN 0046-8177, 06/2016, Volume 52, pp. 201 - 201
Comparative analysis | Histochemistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures
: e1004988
by Adam Pickard and Simon S McDade and Marie McFarland and W Glenn McCluggage and Cosette M Wheeler and Dennis J McCance
PLoS Pathogens, ISSN 1553-7366, 06/2015, Volume 11, Issue 6
  Cervical cancer is a multi-stage disease caused by human papillomaviruses (HPV) infection of cervical epithelial cells, but the mechanisms regulating disease... 
Human papillomavirus | Insulin-like growth factors | Rodents | Cervical cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Timely Follow-up of Positive Cancer Screening Results: A Systematic Review and Recommendation from the PROSPR Consortium
by Doubeni, Chyke A and Gabler, Nicole B and Wheeler, Cosette M and McCarthy, Anne Marie and Castle, Philip E and Halm, Ethan A and Schnall, Mitchell D and Skinner, Celette S and Tosteson, Anna N. A and Weaver, Donald L and Vachani, Anil and Mehta, Shivan J and Rendle, Katharine A and Fedewa, Stacey A and Corley, Douglas A and Armstrong, Katrina
CA: a cancer journal for clinicians, ISSN 0007-9235, 5/2018, Volume 68, Issue 3, pp. 199 - 216
Timely follow-up for positive cancer screening results remains suboptimal and the evidence base to inform decisions on optimizing the timeliness of diagnostic... 
Neoplasm | early diagnosis | lung | cervix uteri | early detection of cancer | colon | mass screening | breast
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Timely Follow-Up of Positive Cancer Screening Results:A Systematic Review and Recommendations Fromthe PROSPR Consortium
by Chyke A Doubeni and Nicole B Gabler and Cosette M Wheeler and Anne Marie McCarthy and Philip E Castle and Ethan A Halm and Mitchell D Schnall and Celette S Skinner and Anna N A Tosteson and Donald L Weaver and Anil Vachani and Shivan J Mehta and Katharine A Rendle and Stacey A Fedewa and Douglas A Corley and Katrina Armstrong
Ca : a Cancer Journal for Clinicians, ISSN 0007-9235, 05/2018, Volume 68, Issue 3, p. 199
Timely follow-up for positive cancer screening results remains suboptimal,and the evidence base to inform decisions on optimizing the timeliness of... 
Systematic review | Medical screening | Cervix | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A study of the impact of adding HPV types to cervical cancer screening and triage test
by Schiffman, Mark and Khan, Michelle J and Solomon, Diane and Herrero, Rolando and Wacholder, Sholom and Hildesheim, Allan and Rodriguez, Ana Cecilia and Bratti, Maria C and Wheeler, Cosette M and Burk, Robert D
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2005, Volume 97, Issue 2, pp. 147 - 150
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium
: Follow-Up of Positive Cancer Screening
by Doubeni, Chyke A and Gabler, Nicole B and Wheeler, Cosette M and McCarthy, Anne Marie and Castle, Philip E and Halm, Ethan A and Schnall, Mitchell D and Skinner, Celette S and Tosteson, Anna N. A and Weaver, Donald L and Vachani, Anil and Mehta, Shivan J and Rendle, Katharine A and Fedewa, Stacey A and Corley, Douglas A and Armstrong, Katrina
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 05/2018, Volume 68, Issue 3, pp. 199 - 216
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
by Kreimer, Aimée R, Dr and Struyf, Frank, MD and Del Rosario-Raymundo, Maria Rowena, MD and Hildesheim, Allan, Prof and Skinner, S Rachel, PhD and Wacholder, Sholom, Prof and Garland, Suzanne M, Prof and Herrero, Rolando, PhD and David, Marie-Pierre, MSc and Wheeler, Cosette M, Dr Prof and Costa Rica Vaccine Trfal PATRICIA and GSK Vaccines Clinical Study Support Group and Costa Rica Vaccine Trial Study Group Authors and PATRICIA Study Group Authors and HPV PATRICIA Principal Investigators/Co-Principal Investigator Collaborators
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Summary Background There is some evidence to suggest that one or two doses of the HPV vaccine provides similar protection to the three-dose regimen. The main... 
Hematology, Oncology and Palliative Medicine | BROAD-SPECTRUM | IMMUNOGENICITY | ONCOLOGY | PARTICLE VACCINE | OF-STUDY ANALYSIS | RANDOMIZED CLINICAL-TRIAL | DOUBLE-BLIND | HPV VACCINE | HUMAN-PAPILLOMAVIRUS | INTRAEPITHELIAL NEOPLASIA | YOUNG-WOMEN | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Age Factors | Follow-Up Studies | United States | Humans | Human papillomavirus 16 - immunology | Costa Rica | Dose-Response Relationship, Drug | Young Adult | Human papillomavirus 16 - isolation & purification | Vaccination - methods | Time Factors | Adult | Female | Papillomavirus Vaccines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Human papillomavirus 18 - isolation & purification | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
by Wheeler, Cosette M, Dr, Prof and Castellsagué, Xavier, PhD and Garland, Suzanne M, Prof and Szarewski, Anne, PhD and Paavonen, Jorma, Prof and Naud, Paulo, Prof and Salmerón, Jorge, Prof and Chow, Song-Nan, Prof and Apter, Dan, MD and Kitchener, Henry, Prof and Teixeira, Júlio C, MD and Skinner, S Rachel, PhD and Jaisamrarn, Unnop, Prof and Limson, Genara, Prof and Romanowski, Barbara, Prof and Aoki, Fred Y, Prof and Schwarz, Tino F, Prof and Poppe, Willy A J, Prof and Bosch, F Xavier, PhD and Harper, Diane M, MD and Huh, Warner, MD and Hardt, Karin, PhD and Zahaf, Toufik, PhD and Descamps, Dominique, MD and Struyf, Frank, MD and Dubin, Gary, MD and Lehtinen, Matti, Prof and HPV PATRICIA Study Grp and HPV PATRICIA Study Group
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text TNF-α promoter polymorphisms and susceptibility to human papiflomavirus 16-associated cervical cancer
by Deshpande, Alina and Nolan, John P and White, P. Scott and Valdez, Yolanda E and Hunt, William C and Peyton, Cheri L and Wheeler, Cosette M
Journal of Infectious Diseases, ISSN 0022-1899, 03/2005, Volume 191, Issue 6, pp. 969 - 976
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
by Lehtinen, Matti, Prof and Paavonen, Jorma, Prof and Wheeler, Cosette M, Prof and Jaisamrarn, Unnop, Prof and Garland, Suzanne M, Prof and Castellsagué, Xavier, PhD and Skinner, S Rachel, PhD and Apter, Dan, MD and Naud, Paulo, Prof and Salmerón, Jorge, Prof and Chow, Song-Nan, Prof and Kitchener, Henry, Prof and Teixeira, Júlio C, MD and Hedrick, James, MD and Limson, Genara, Prof and Szarewski, Anne, PhD and Romanowski, Barbara, Prof and Aoki, Fred Y, Prof and Schwarz, Tino F, Prof and Poppe, Willy A J, Prof and De Carvalho, Newton S, Prof and Germar, Maria Julieta V, MD and Peters, Klaus, MD and Mindel, Adrian, Prof and De Sutter, Philippe, MD and Bosch, F Xavier, PhD and David, Marie-Pierre, MSc and Descamps, Dominique, MD and Struyf, Frank, MD and Dubin, Gary, MD and PATRICIA Study Grp and HPV PATRICIA Study Group
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Human papillomavirus testing 2007-2012: Co-testing and triage utilization and impact on subsequent clinical management
: HPV test utilization
by Cuzick, Jack and Myers, Orrin and Hunt, William C and Saslow, Debbie and Castle, Philip E and Kinney, Walter and Waxman, Alan and Robertson, Michael and Wheeler, Cosette M and on behalf of the New Mexico HPV Pap Registry Steering Committee
International Journal of Cancer, ISSN 0020-7136, 06/2015, Volume 136, Issue 12, pp. 2854 - 2863
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights